P&T Committee

The Pharmacy and Therapeutics (P&T) Committee provides recommendations for the Medicaid Preferred Drug List (PDL). The Committee is composed of Physicians & Pharmacists who meet at least quarterly to consider PDL implementation. These meetings are generally scheduled on the third Thursday of every month at 7:00 A.M. in the Cannon Health Building at 288 N. 1460 W. in Salt Lake City, UT. The P&T Committee reserves the right to adjust the meeting schedule as necessary. Notices for exact meeting times and locations will be published in the Legal Notices sections of the Salt Lake Newspapers at least 24 hours in advance.

The meetings are open to the public. To receive public notice for this meeting by email please sign up on the Utah Public Notice website.

Public Comments for the P&T Committee:

Public comment that responds to the materials presented by the Pharmacotherapy Outcomes Research Center at the Universityof Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-Based Practice Center or the Pharmacotherapy Outcomes Research Center and are posted in advance on the P&T Committee website

Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to:

Gary M. Oderda, Pharm.D., M.P.H
Professor and Director
Pharmacotherapy Outcomes Research Center
University of Utah College of Pharmacy
421 Wakara Way Suite 208
Salt Lake City, UT 84108

All materials must be clearly labeled that they are submitted for consideration as part of the State of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.

Persons who wish to address the P&T Committee may contact Lisa Hunt by phone at 801-538-6317 or by email at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints

Listed below is a P&T Committee class review tentative schedule:

P&T Tentative Schedule:

April 2014: Annual Training AND Epipen Formulations
May 2014: Antihistamines 1st Generation Agents AND Antihistamines 2nd Generation Agents
June 2014: No Meeting
July 2014: Vitamin D Analogs AND Bile Acid Sequestrants
August 2014: Amebicide Anti-Infective Agents AND Macrolide Antibiotics
September 2014: Aminoglycosides AND Tetracyclines
October 2014: Thiazide Diuretic Agents AND Loop Diuretics
November 2014: Potassium-Sparing Diuretics AND Agents used to treat Angina
December 2014: Beta-Lactams and Clavulanate Combos

Listed below are meeting minutes, recordings, agendas, criteria review documents, and reports regarding the P&T Committee. Clinical evidence documents prepared for the P&T Committee meetings will be kept on this website for 6 months.

Meeting recordings will be available online for 1 year. For historical meeting recordings please contact us at medicaidpharmacy@utah.gov.

Current Criteria Review Documents available include:

October 2013: 5-Aminosalacylic Acid Derivatives
November 2013: Phosphate Binding Agents
December 2013: Topical Immune Modulators AND Topical Analgesics and Anesthetics
January 2014: Pediculicide and Scabicide Agents
February 2014: Short-Acting Opioid Agents
March 2014: Antiemetic Agents AND Appetite Stimulant Agents

The documents are provided in Adobe format. If you cannot view a file, please download the free plug-in from the link below.

Get Adobe Acrobat Reader

Name Type Last Modified
Parent Directory  
AUG.07.pdfpdf October 04, 2007
Dec.07.PT.pdfpdf February 14, 2008
June.07.pdfpdf September 06, 2007
MAY.07.pdfpdf June 28, 2007
NOV.07.pdfpdf April 09, 2014
OCT.07.pdfpdf December 04, 2007
SEPT.07.pdfpdf October 30, 2007